-
Posted by
Two Blokes Jun 17 -
Filed in
Stock
-
3 views
Toronto, Ontario – TheNewswire – June 17, 202 5 - Ventripoint Diagnostics Ltd. (“ Ventripoint ” or the “ Corporation ”) (TSXV:VPT, OTC:VPTDF) is providing an update on options. On March 12, 2025, the Corporation issued 500,000 option grants at $0.15 and 500,000 option grants at $0.20 to contractors to the Corporation. These option grants vested over 4 months and had a term of two years. On June 2, 2025, the Corporation issued 2,000,000 option grants at $0.10 to employees, consultants and advisors. The option grants vested from immediately to over 3 years and had a term for two to ten years. On June 12, 2025, the Corporation 1,635,000 option grants at $0.10 to employees, consultants and advisors. The option grants vested from immediately to over 3 months and had a term for two years. None of the above option grants were awarded to directors of officers of the Corporation. Since the last update (see NR February 11, 2024), a total of 3,119,450 options were exercised with a weighted average price of approximately $0.11 per share for gross proceeds to the Corporation of $356,385. In addition, 1,994,500 options expired. There are currently 13,100,750 option grants outstanding with exercise prices between $0.10 to $0.50 with a weighted average exercise price of $0.20, and 11,083,250 of these options have vested.
